Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D051381:Rats; D013268:Stimulation, Chemical
D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine